Frontlight ResearchEarly access
Trial site
Tengzhou Central People's Hospital
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer3 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 24 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Not yet recruiting3 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Qilu Hospital of Shandong University2 trials
- Antengene Biologics Limited1 trial
- Beijing Tiantan Hospital1 trial
- Kunming Pharmaceuticals, Inc.1 trial
- Peking University First Hospital1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Recruiting
Not yet recruiting
Recruiting
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer3 recruiting
- Coronary artery disease1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026